Jacob Johnson
Stock Analyst at Stephens & Co.
(3.51)
# 972
Out of 4,667 analysts
83
Total ratings
44.07%
Success rate
7.37%
Average return
Main Sectors:
Stocks Rated by Jacob Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STE STERIS | Reiterates: Overweight | $260 | $212.25 | +22.50% | 6 | Nov 7, 2024 | |
| DHR Danaher | Reiterates: Overweight | $315 | $233.10 | +35.14% | 2 | Oct 23, 2024 | |
| TMO Thermo Fisher | Initiates: Overweight | $680 | $512.84 | +32.59% | 1 | Oct 1, 2024 | |
| CDMO Avid Bioservices | Reiterates: Overweight | $12 | $12.22 | -1.80% | 7 | Sep 10, 2024 | |
| RGEN Repligen | Reiterates: Overweight | $170 | $138.90 | +22.39% | 4 | Jul 30, 2024 | |
| TKNO Alpha Teknova | Reiterates: Overweight | $5 | $7.74 | -35.40% | 5 | Jul 10, 2024 | |
| MASS 908 Devices | Reiterates: Overweight | $14 | $2.56 | +446.88% | 3 | May 13, 2024 | |
| MXCT MaxCyte | Reiterates: Overweight | $11 | $3.49 | +215.19% | 5 | Apr 23, 2024 | |
| CTLT Catalent | Reiterates: Equal-Weight | $64 | $59.00 | +7.63% | 4 | Apr 4, 2024 | |
| STVN Stevanato Group | Reiterates: Overweight | $38 | $18.27 | +107.99% | 2 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $17 | $6.57 | +158.75% | 3 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $2.5 | $1.66 | +50.60% | 3 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $70 | $44.65 | +56.77% | 4 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $87 | $68.72 | +26.60% | 10 | Feb 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $390 | $311.66 | +25.14% | 8 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $9 | $7.48 | +20.32% | 3 | Sep 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $16 → $18 | $15.36 | +17.19% | 5 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $6 | $4.33 | +38.57% | 2 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $27 → $29 | $25.01 | +15.95% | 3 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $153 → $130 | $111.56 | +16.53% | 2 | May 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $377 | $187.90 | +100.64% | 1 | Apr 7, 2022 |
STERIS
Nov 7, 2024
Reiterates: Overweight
Price Target: $260
Current: $212.25
Upside: +22.50%
Danaher
Oct 23, 2024
Reiterates: Overweight
Price Target: $315
Current: $233.10
Upside: +35.14%
Thermo Fisher
Oct 1, 2024
Initiates: Overweight
Price Target: $680
Current: $512.84
Upside: +32.59%
Avid Bioservices
Sep 10, 2024
Reiterates: Overweight
Price Target: $12
Current: $12.22
Upside: -1.80%
Repligen
Jul 30, 2024
Reiterates: Overweight
Price Target: $170
Current: $138.90
Upside: +22.39%
Alpha Teknova
Jul 10, 2024
Reiterates: Overweight
Price Target: $5
Current: $7.74
Upside: -35.40%
908 Devices
May 13, 2024
Reiterates: Overweight
Price Target: $14
Current: $2.56
Upside: +446.88%
MaxCyte
Apr 23, 2024
Reiterates: Overweight
Price Target: $11
Current: $3.49
Upside: +215.19%
Catalent
Apr 4, 2024
Reiterates: Equal-Weight
Price Target: $64
Current: $59.00
Upside: +7.63%
Stevanato Group
Mar 25, 2024
Reiterates: Overweight
Price Target: $38
Current: $18.27
Upside: +107.99%
Mar 13, 2024
Reiterates: Equal-Weight
Price Target: $17
Current: $6.57
Upside: +158.75%
Mar 7, 2024
Reiterates: Equal-Weight
Price Target: $2.5
Current: $1.66
Upside: +50.60%
Feb 8, 2024
Reiterates: Equal-Weight
Price Target: $70
Current: $44.65
Upside: +56.77%
Feb 2, 2024
Maintains: Overweight
Price Target: $92 → $87
Current: $68.72
Upside: +26.60%
Oct 27, 2023
Maintains: Overweight
Price Target: $420 → $390
Current: $311.66
Upside: +25.14%
Sep 1, 2023
Maintains: Equal-Weight
Price Target: $8 → $9
Current: $7.48
Upside: +20.32%
Aug 21, 2023
Upgrades: Overweight
Price Target: $16 → $18
Current: $15.36
Upside: +17.19%
Jul 21, 2023
Reiterates: Overweight
Price Target: $6
Current: $4.33
Upside: +38.57%
Jul 17, 2023
Maintains: Overweight
Price Target: $27 → $29
Current: $25.01
Upside: +15.95%
May 16, 2022
Maintains: Overweight
Price Target: $153 → $130
Current: $111.56
Upside: +16.53%
Apr 7, 2022
Initiates: Overweight
Price Target: $377
Current: $187.90
Upside: +100.64%